1. Home
  2. BGLC vs DSS Comparison

BGLC vs DSS Comparison

Compare BGLC & DSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BGLC
  • DSS
  • Stock Information
  • Founded
  • BGLC 2017
  • DSS 1984
  • Country
  • BGLC Malaysia
  • DSS United States
  • Employees
  • BGLC N/A
  • DSS N/A
  • Industry
  • BGLC Medical Specialities
  • DSS Containers/Packaging
  • Sector
  • BGLC Health Care
  • DSS Consumer Discretionary
  • Exchange
  • BGLC Nasdaq
  • DSS Nasdaq
  • Market Cap
  • BGLC 10.4M
  • DSS 11.7M
  • IPO Year
  • BGLC N/A
  • DSS N/A
  • Fundamental
  • Price
  • BGLC $5.40
  • DSS $1.09
  • Analyst Decision
  • BGLC
  • DSS
  • Analyst Count
  • BGLC 0
  • DSS 0
  • Target Price
  • BGLC N/A
  • DSS N/A
  • AVG Volume (30 Days)
  • BGLC 99.3K
  • DSS 60.0K
  • Earning Date
  • BGLC 11-14-2025
  • DSS 11-14-2025
  • Dividend Yield
  • BGLC N/A
  • DSS N/A
  • EPS Growth
  • BGLC N/A
  • DSS N/A
  • EPS
  • BGLC N/A
  • DSS N/A
  • Revenue
  • BGLC $9,551,559.00
  • DSS $21,252,000.00
  • Revenue This Year
  • BGLC N/A
  • DSS N/A
  • Revenue Next Year
  • BGLC N/A
  • DSS N/A
  • P/E Ratio
  • BGLC N/A
  • DSS N/A
  • Revenue Growth
  • BGLC 4.01
  • DSS 10.24
  • 52 Week Low
  • BGLC $2.01
  • DSS $0.72
  • 52 Week High
  • BGLC $15.60
  • DSS $1.90
  • Technical
  • Relative Strength Index (RSI)
  • BGLC 52.88
  • DSS 32.19
  • Support Level
  • BGLC $5.00
  • DSS $1.11
  • Resistance Level
  • BGLC $5.37
  • DSS $1.30
  • Average True Range (ATR)
  • BGLC 0.34
  • DSS 0.08
  • MACD
  • BGLC 0.02
  • DSS -0.03
  • Stochastic Oscillator
  • BGLC 61.14
  • DSS 2.78

About BGLC BioNexus Gene Lab Corp Common stock

BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.

About DSS DSS Inc.

DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia. Product packaging manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through represents its banking and financing business line. Alternative Trading develops and/or acquires assets and investments in the securities trading and/or fund management arena.

Share on Social Networks: